Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nationwide Study: Good Outcome in Skin Melanoma and Hodgkin Lymphoma.
Marjańska A, Pawińska-Wąsikowska K, Wieczorek A, Drogosiewicz M, Dembowska-Bagińska B, Bobeff K, Młynarski W, Adamczewska-Wawrzynowicz K, Wachowiak J, Krawczyk MA, Irga-Jaworska N, Węcławek-Tompol J, Kałwak K, Sawicka-Żukowska M, Krawczuk-Rybak M, Raciborska A, Mizia-Malarz A, Sobocińska-Mirska A, Łaguna P, Balwierz W, Styczyński J. Marjańska A, et al. Among authors: wieczorek a. Cancers (Basel). 2024 Feb 28;16(5):968. doi: 10.3390/cancers16050968. Cancers (Basel). 2024. PMID: 38473329 Free PMC article.
Go with the Flow-Early Assessment of Measurable Residual Disease in Children with Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM2009.
Pawinska-Wasikowska K, Bukowska-Strakova K, Surman M, Rygielska M, Sadowska B, Ksiazek T, Klekawka T, Wieczorek A, Skoczen S, Balwierz W. Pawinska-Wasikowska K, et al. Among authors: wieczorek a. Cancers (Basel). 2022 Oct 30;14(21):5359. doi: 10.3390/cancers14215359. Cancers (Basel). 2022. PMID: 36358778 Free PMC article.
Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children-the Polish Pediatric Leukemia and Lymphoma Study Group experience.
Pawinska-Wasikowska K, Czogala M, Skoczen S, Surman M, Rygielska M, Ksiazek T, Pac A, Wieczorek A, Skalska-Sadowska J, Samborska M, Wachowiak J, Chaber R, Tomaszewska R, Szczepanski T, Zielezinska K, Urasinski T, Moj-Hackemer M, Kalwak K, Kozlowska M, Irga-Jaworska N, Balwierz W, Bukowska-Strakova K. Pawinska-Wasikowska K, et al. Among authors: wieczorek a. Front Immunol. 2023 Dec 22;14:1268993. doi: 10.3389/fimmu.2023.1268993. eCollection 2023. Front Immunol. 2023. PMID: 38187390 Free PMC article.
The Role of Id2 Protein in Neuroblatoma in Children.
Wieczorek A, Balwierz W. Wieczorek A, et al. Pathol Oncol Res. 2015 Sep;21(4):999-1004. doi: 10.1007/s12253-015-9908-9. Epub 2015 Mar 14. Pathol Oncol Res. 2015. PMID: 25771836 Free PMC article.
Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy.
Lode HN, Ladenstein R, Troschke-Meurer S, Struppe L, Siebert N, Zumpe M, Ehlert K, Huber S, Glogova E, Hundsdoerfer P, Eggert A, Zaniewska-Tekieli A, Balwierz W, Wieczorek A. Lode HN, et al. Among authors: wieczorek a. Cancers (Basel). 2023 Jun 27;15(13):3364. doi: 10.3390/cancers15133364. Cancers (Basel). 2023. PMID: 37444475 Free PMC article.
334 results